Cargando…

Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19

BACKGROUND: COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications can be the presenting manifestation in a subset of infected patients. CASE PRESENTATION: We describe a 78-year old immunocompromis...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhadian, Shelli, Glick, Laura R., Vogels, Chantal B. F., Thomas, Jared, Chiarella, Jennifer, Casanovas-Massana, Arnau, Zhou, Jing, Odio, Camila, Vijayakumar, Pavithra, Geng, Bertie, Fournier, John, Bermejo, Santos, Fauver, Joseph R., Alpert, Tara, Wyllie, Anne L., Turcotte, Cynthia, Steinle, Matthew, Paczkowski, Patrick, Dela Cruz, Charles, Wilen, Craig, Ko, Albert I., MacKay, Sean, Grubaugh, Nathan D., Spudich, Serena, Barakat, Lydia Aoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301053/
https://www.ncbi.nlm.nih.gov/pubmed/32552792
http://dx.doi.org/10.1186/s12883-020-01812-2
_version_ 1783547613133406208
author Farhadian, Shelli
Glick, Laura R.
Vogels, Chantal B. F.
Thomas, Jared
Chiarella, Jennifer
Casanovas-Massana, Arnau
Zhou, Jing
Odio, Camila
Vijayakumar, Pavithra
Geng, Bertie
Fournier, John
Bermejo, Santos
Fauver, Joseph R.
Alpert, Tara
Wyllie, Anne L.
Turcotte, Cynthia
Steinle, Matthew
Paczkowski, Patrick
Dela Cruz, Charles
Wilen, Craig
Ko, Albert I.
MacKay, Sean
Grubaugh, Nathan D.
Spudich, Serena
Barakat, Lydia Aoun
author_facet Farhadian, Shelli
Glick, Laura R.
Vogels, Chantal B. F.
Thomas, Jared
Chiarella, Jennifer
Casanovas-Massana, Arnau
Zhou, Jing
Odio, Camila
Vijayakumar, Pavithra
Geng, Bertie
Fournier, John
Bermejo, Santos
Fauver, Joseph R.
Alpert, Tara
Wyllie, Anne L.
Turcotte, Cynthia
Steinle, Matthew
Paczkowski, Patrick
Dela Cruz, Charles
Wilen, Craig
Ko, Albert I.
MacKay, Sean
Grubaugh, Nathan D.
Spudich, Serena
Barakat, Lydia Aoun
author_sort Farhadian, Shelli
collection PubMed
description BACKGROUND: COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications can be the presenting manifestation in a subset of infected patients. CASE PRESENTATION: We describe a 78-year old immunocompromised woman who presented with altered mental status after witnessed seizure-like activity at home. She was found to have SARS-CoV-2 infection and associated neuroinflammation. In this case, we undertake the first detailed analysis of cerebrospinal fluid (CSF) cytokines during COVID-19 infection and find a unique pattern of inflammation in CSF, but no evidence of viral neuroinvasion. CONCLUSION: Our findings suggest that neurologic symptoms such as encephalopathy and seizures may be the initial presentation of COVID-19. Central nervous system inflammation may associate with neurologic manifestations of disease.
format Online
Article
Text
id pubmed-7301053
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73010532020-06-18 Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 Farhadian, Shelli Glick, Laura R. Vogels, Chantal B. F. Thomas, Jared Chiarella, Jennifer Casanovas-Massana, Arnau Zhou, Jing Odio, Camila Vijayakumar, Pavithra Geng, Bertie Fournier, John Bermejo, Santos Fauver, Joseph R. Alpert, Tara Wyllie, Anne L. Turcotte, Cynthia Steinle, Matthew Paczkowski, Patrick Dela Cruz, Charles Wilen, Craig Ko, Albert I. MacKay, Sean Grubaugh, Nathan D. Spudich, Serena Barakat, Lydia Aoun BMC Neurol Case Report BACKGROUND: COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications can be the presenting manifestation in a subset of infected patients. CASE PRESENTATION: We describe a 78-year old immunocompromised woman who presented with altered mental status after witnessed seizure-like activity at home. She was found to have SARS-CoV-2 infection and associated neuroinflammation. In this case, we undertake the first detailed analysis of cerebrospinal fluid (CSF) cytokines during COVID-19 infection and find a unique pattern of inflammation in CSF, but no evidence of viral neuroinvasion. CONCLUSION: Our findings suggest that neurologic symptoms such as encephalopathy and seizures may be the initial presentation of COVID-19. Central nervous system inflammation may associate with neurologic manifestations of disease. BioMed Central 2020-06-18 /pmc/articles/PMC7301053/ /pubmed/32552792 http://dx.doi.org/10.1186/s12883-020-01812-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Farhadian, Shelli
Glick, Laura R.
Vogels, Chantal B. F.
Thomas, Jared
Chiarella, Jennifer
Casanovas-Massana, Arnau
Zhou, Jing
Odio, Camila
Vijayakumar, Pavithra
Geng, Bertie
Fournier, John
Bermejo, Santos
Fauver, Joseph R.
Alpert, Tara
Wyllie, Anne L.
Turcotte, Cynthia
Steinle, Matthew
Paczkowski, Patrick
Dela Cruz, Charles
Wilen, Craig
Ko, Albert I.
MacKay, Sean
Grubaugh, Nathan D.
Spudich, Serena
Barakat, Lydia Aoun
Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
title Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
title_full Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
title_fullStr Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
title_full_unstemmed Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
title_short Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
title_sort acute encephalopathy with elevated csf inflammatory markers as the initial presentation of covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301053/
https://www.ncbi.nlm.nih.gov/pubmed/32552792
http://dx.doi.org/10.1186/s12883-020-01812-2
work_keys_str_mv AT farhadianshelli acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT glicklaurar acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT vogelschantalbf acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT thomasjared acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT chiarellajennifer acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT casanovasmassanaarnau acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT zhoujing acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT odiocamila acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT vijayakumarpavithra acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT gengbertie acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT fournierjohn acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT bermejosantos acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT fauverjosephr acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT alperttara acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT wyllieannel acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT turcottecynthia acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT steinlematthew acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT paczkowskipatrick acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT delacruzcharles acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT wilencraig acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT koalberti acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT mackaysean acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT grubaughnathand acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT spudichserena acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19
AT barakatlydiaaoun acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19